#case | treatment | duration of treatment | number of p53-positive cells | intensity | percentage of Ki67-positive cells |
---|---|---|---|---|---|
0694-2 | control | 11 | 0 - 1 | n.d. | |
10 μM nutlin-3 | 72 h | 393 | 2 | n.d. | |
30 μM nutlin-3 | 1, 277 | 3 | n.d. | ||
0695-0 | control | 0 | 0 | 4% | |
10 μM nutlin-3 | 11 | 1 | < 1% | ||
30 μM nutlin-3 | 188 | 1 | < 1% | ||
0695-1 | control | 0 | 0 | - | |
10 μM nutlin-3 | 42 | 0 - 1 | - | ||
30 μM nutlin-3 | 6 days | 89 | 1 | - | |
0695-2 | control | 0 | 0 | < 1% | |
10 μM nutlin-3 | 194 | 1 - 2 | - | ||
30 μM nutlin-3 | 799 | 3 | - | ||
0695-3 | control | 0 | 0 | < 1% | |
10 μM nutlin-3 | 770 | 3 | |||
30 μM nutlin-3 | 1, 493 | 3 | |||
0687-0 | control | 0 | 0 | n.d. | |
10 μM nutlin-3 | 2 | 1 | n.d. | ||
30 μM nutlin-3 | 72 h | 257 | 2 | n.d. | |
0687-1 | control | 0 | 0 | n.d. | |
10 μM nutlin-3 | 398 | 2 | n.d. | ||
30 μM nutlin-3 | n.d. | n.d. | n.d. |